Xconomy’s Digital Events →
Tim Springer is an immunologist at Harvard University and the scientific founder of Morphic Therapeutics.
Sponsored · Whitepaper
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
Sponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.